Beta Drugs Share price target & analyst calls

₹1,971+306.30 (+18.40%)

As of 22 Oct 2026

No positional price targets right nowLast 1-year target: ₹2,245 from Nuvama Wealth (8 Nov 2024) · expired

none open right now

—

no positional targets

N/A

2 of 10 closed calls needed

all horizons, open and closed

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

1 upcoming · Technicals

Q2 FY27 results scheduled — board meets 22 Oct 2026

Earnings calendar

22 Oct 2026

Not investment advice.

46.1

Neutral

−7.2% (₹2,123.13)

Bearish

+15.2% (₹1,711.47)

Bullish

26.1% below high · 91.3% above low

Context

567K · 11.3×

Unusual

Technical indicators are computed from exchange prices. Not investment advice.

BUYTarget₹1,600⚙︎

1 Year* · 16 May 2024 · entry ₹1,179.9 · via Institutional / Brokerage Researchexit ₹1,600

BUYTarget₹2,245⚙︎

1 Year* · 8 Nov 2024 · entry ₹2,194 · via Institutional / Brokerage Researchexit ₹1,753.71

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Most-covered stocks in the sector · average 1-year target